Announcements
Projects
Orgs
Project
Articles 2
Votes 0
Novavax.com
Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. - Oct 3, 2023 - Novavax Investor Relations
>2y
Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses - Novavax Investor Relations
>2y